2nd Quarter - Report
DAVIS & HARMAN LLP for EMERGENT BIOSOLUTIONS, INC.
Firm
Client
Income
$20,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the Antthrax vaccine and other bipharmaceutical products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS A DAVIS | — |
Budget/Appropriations BUD
Issues related to the Anthrax vaccine and other biopharmaceutical products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS A DAVIS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.